Lung Cancer

Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.

Walt Disney died of lung cancer, leaving an important lesson to my son.

I wrote this heart-felt poem after watching my father pass away from stage 4 lung cancer.

I've found that nutrition and healthy foods play an important role during cancer.

Writing poetry helped me process the grief of losing my mom to metastatic lung cancer.

Some patients with limited-stage small cell lung cancer experienced overall survival benefits and progression-free survival via treatment with Imfinzi.

A clinical trial has started to evaluate the investigational drug MK-1084 and Keytruda among some patients with metastatic non-small cell lung cancer.

During cancer, we all share a common denominator: hope.

Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.

Dendritic cell maturation agent plinabulin, immunotherapy and chemotherapy are being studied in first-line extensive-stage small cell lung cancer.

Comprehensive biomarker testing and “timely” testing is “important” for patients with a specific lung cancer subset, an expert said.

Throughout my life, taking walks helped a lot with easing anxiety, so walking helped me when I received two diagnoses of cancer.

As part of its Speaking Out video series, CURE® spoke with Lisa Carter-Bawa of Hackensack Meridian Health about the role nurses play in helping patients manage treatment side effects.

As part of its Speaking Out video series, CURE® spoke with Upal Basu Roy of LUNGevity about recently approved treatments for lung cancer and what is on the horizon.

As part of its Speaking Out video series, CURE® spoke with Amy C. Moore of LUNGevity about the chemotherapy shortage and its impact on patients with lung cancer.

As part of its Speaking Out video series, CURE® spoke with Amy C. Moore of Lungevity about advancements in treatments for small cell lung cancer.

As part of its Speaking Out video series, CURE® spoke with Brandon Leonard of the LUNGevity Foundation about the role legislation can play in a patient’s cancer journey.

Certain patients with lung cancer who have EGFR exon 20 insertion mutations may have a new treatment option, which welcomes a new “milestone.”

As a three-time cancer survivor, I wonder: are my roots damaged or resting to find their way?

After having early-stage breast cancer and stage 3B lung cancer, I'm choosing to give back. Here's how.

The CURE® 2024 Lung Cancer Special Issue provides insight into the ever-changing innovation in the lung cancer space.

This special issue of CURE Lung Cancer takes a deeper dive into ALK-positive non-small cell lung cancer.

Patients with small cell lung cancer have reasons to be optimistic these days, as one expert explains to CURE.

What advancements for ALK-positive non-small cell lung cancer are on the way, from treating earlier stages of disease to postsurgical options?

The Food and Drug Administration approved Rybrevant plus carboplatin and pemetrexed for locally advanced or metastatic non-small cell lung cancer (NSCLC) that has EGFR exon 20 insertion mutations.